ATE366119T1 - Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung - Google Patents

Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung

Info

Publication number
ATE366119T1
ATE366119T1 AT00951893T AT00951893T ATE366119T1 AT E366119 T1 ATE366119 T1 AT E366119T1 AT 00951893 T AT00951893 T AT 00951893T AT 00951893 T AT00951893 T AT 00951893T AT E366119 T1 ATE366119 T1 AT E366119T1
Authority
AT
Austria
Prior art keywords
medicament
chitosan powder
large intestine
production
release
Prior art date
Application number
AT00951893T
Other languages
English (en)
Inventor
Norihito Shimono
Masaaki Mori
Yutaka Higashi
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE366119T1 publication Critical patent/ATE366119T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00951893T 1999-08-09 2000-08-07 Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung ATE366119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22477799 1999-08-09

Publications (1)

Publication Number Publication Date
ATE366119T1 true ATE366119T1 (de) 2007-07-15

Family

ID=16819059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951893T ATE366119T1 (de) 1999-08-09 2000-08-07 Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung

Country Status (11)

Country Link
US (1) US7604820B1 (de)
EP (1) EP1203590B1 (de)
JP (1) JP4659316B2 (de)
KR (1) KR20020015721A (de)
CN (1) CN1162183C (de)
AT (1) ATE366119T1 (de)
AU (1) AU778049B2 (de)
CA (1) CA2378265C (de)
DE (1) DE60035421T2 (de)
ES (1) ES2288152T3 (de)
WO (1) WO2001010467A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
WO2005030173A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Colon-specific drug delivery using interpolymer complexations
DE102004059792A1 (de) 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP5386176B2 (ja) * 2006-12-21 2014-01-15 フロイント産業株式会社 キトサン溶液及び該溶液から形成されたキトサンコーティング製剤
JP2009191036A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
EP2371356B1 (de) * 2010-03-12 2012-12-19 Phoeme GmbH Pharmazeutische Mehrfachpartikelformulierung zur Kolonabsorption
JP5087167B2 (ja) * 2010-12-28 2012-11-28 フロイント産業株式会社 ビフィズス菌大腸デリバリーカプセル及びその製造方法
JP2014529630A (ja) * 2011-09-07 2014-11-13 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
WO2013054285A1 (en) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
JP5102401B1 (ja) 2012-03-30 2012-12-19 森下仁丹株式会社 大腸特異崩壊性カプセル
JP6062802B2 (ja) * 2012-08-23 2017-01-18 日清ファルマ株式会社 キトサン含有組成物及びキトサンコーティング組成物
CN104968356A (zh) * 2012-12-21 2015-10-07 日清药业股份有限公司 大肠输送胶囊及其制备方法
CN115192537B (zh) * 2022-07-27 2024-03-26 康普药业股份有限公司 一种甲磺酸萘莫司他组合物及其制备方法
CN119185241B (zh) * 2024-10-08 2025-10-10 福建省闽东力捷迅药业股份有限公司 一种奥匹卡朋缓释微丸

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
JPH064531B2 (ja) * 1990-06-04 1994-01-19 アイセロ化学株式会社 大腸崩壊性硬質カプセル
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
GB2255344B (en) 1990-08-30 1994-07-20 Warner Lambert Co Composition comprising a hydrophilic polymer and a hydrophilic material different therefrom
JP3181062B2 (ja) * 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
JP3122478B2 (ja) 1991-02-19 2001-01-09 帝國製薬株式会社 下部消化管放出型経口製剤
JP3282832B2 (ja) 1991-02-19 2002-05-20 帝國製薬株式会社 持続性錠剤
JP3592723B2 (ja) 1991-02-19 2004-11-24 帝國製薬株式会社 非崩壊・持続性カプセル製剤
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JP2521229B2 (ja) 1993-06-17 1996-08-07 アイセロ化学株式会社 大腸崩壊性組成物及びその製造法
ES2188657T3 (es) 1994-04-22 2003-07-01 Yamanouchi Pharma Co Ltd Sistema para la liberacion especifica en el colon de un farmaco.
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP2001519379A (ja) 1997-10-09 2001-10-23 ペリオ、プロダクツ、リミテッド 遅延性総放出胃腸薬物送達システム
US6197322B1 (en) * 1997-12-23 2001-03-06 Kimberly-Clark Worldwide, Inc. Antimicrobial structures

Also Published As

Publication number Publication date
CA2378265A1 (en) 2001-02-15
CA2378265C (en) 2007-11-20
DE60035421D1 (de) 2007-08-16
CN1377281A (zh) 2002-10-30
EP1203590A4 (de) 2005-01-19
EP1203590A1 (de) 2002-05-08
AU6472300A (en) 2001-03-05
KR20020015721A (ko) 2002-02-28
US7604820B1 (en) 2009-10-20
EP1203590B1 (de) 2007-07-04
WO2001010467A1 (fr) 2001-02-15
CN1162183C (zh) 2004-08-18
DE60035421T2 (de) 2008-03-13
HK1044286A1 (en) 2002-10-18
JP4659316B2 (ja) 2011-03-30
ES2288152T3 (es) 2008-01-01
AU778049B2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
DE60035421D1 (de) Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung
Bose et al. Solventless pharmaceutical coating processes: a review
DE69915184D1 (de) Pharmazeutische Formulierung und Dosierform bestehend aus Polysacchariden zur kontrollierten Wirkstoff-Freisetzung im Dickdarm
EP1803473A3 (de) Medikament enthaltender Klebstoff
ATE222487T1 (de) Brausemittel und dessen herstellung
CA2302276A1 (en) Methods of treating capsules and dry, powdered pharmaceutical formulations
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
ATE261311T1 (de) Biologisch abbaubare nanopartikel mit kontrollierter freigabe von insulin
EP0871435A4 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
ATE213936T1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
DK0752245T3 (da) Biokompatible og bionedbrydelige nanopartikler udviklet til absorption og afgivelse af proteinholdige lægemidler
EP0804166A4 (de) Formulierungen mit kontrollierter abgabe (albuterol)
DE69630375D1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
HUT53813A (en) Coating material controlling release of medicaments
AU4800999A (en) Preparation capable of releasing drug at target site in intestine
BRPI0409962A (pt) co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente
IL84167A (en) Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
HU908477D0 (en) Process for the production of medical preparations with controlled content of active agents
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
PT1693054T (pt) Polímero de ácido láctico e processo para a sua produção
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE59710629D1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
AU6251094A (en) Bisacodyl dosage form
DE60008497D1 (de) Arzneimittel zur oralen verabreichung
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties